Sensocure AS shall be a prestigious and innovative medtech company in forefront of new technology development for treatment of ischemia and other major disease groups.

Sensocure will have the potential to become the market leader in postoperative monitoring of internal organs. The most relevantsegments accounted for 2+ million procedures annually worldwide in 2011.

The company is now working towards the following goals: "By the end of a two-year development program the first sensor will be ready for industrialization. The company will also have market channels ready to accept the sensor."